During the past decade, Dept of Internal Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dept of Internal Medicine" #1 sponsor was "Medical University of Vienna" with 5 trials, followed by "Karyopharm Therapeutics Inc" with 1 trials sponsored, "Michael Frass" with 1 trials sponsored, "Prof. Dr. Matthias Preusser" with 1 trials sponsored and "Rain Oncology Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Dept of Internal Medicine" are "Colorectal Cancer" (1 trials), "Dedifferentiated Liposarcoma" (1 trials), "Hormone Refractory Prostate Cancer" (1 trials), "MALT Lymphoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Dept of Internal Medicine" in a lesser frequency.

Most popular intervention types in "Dept of Internal Medicine" are "Drug" (7 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (1 trials), "Combitube" (1 trials), "Dexamethasone" (1 trials), "Docetaxel" (1 trials) and "Docetaxel * Sunitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept of Internal Medicine" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dept of Internal Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dept of Internal Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dept of Internal Medicine, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".